C19orf18 encompass a diverse group of compounds that can induce a spectrum of intracellular signaling pathways leading to its activation. 6-Benzylaminopurine, a plant hormone, initiates a cascade of cellular events that promote cell division and growth, which can activate C19orf18 as it participates in these processes. Forskolin directly stimulates adenylate cyclase to raise cyclic AMP (cAMP) levels, thereby activating protein kinase A (PKA), which in turn may phosphorylate C19orf18. Similarly, dibutyryl-cAMP, a cell-permeable cAMP analog, can also trigger PKA or exchange protein activated by cAMP (EPAC), potentially leading to the activation of C19orf18. Phorbol 12-myristate 13-acetate (PMA) is known for activating protein kinase C (PKC), which has a broad role in cell signaling and may phosphorylate C19orf18 as part of its signaling cascade. Ionomycin acts by increasing intracellular calcium levels, thereby activating calcium-dependent kinases or phosphatases that may target C19orf18 within calcium signaling pathways. Isoproterenol, a beta-adrenergic agonist, stimulates adenylyl cyclase through G-protein coupled receptor signaling, which could also lead to the activation of C19orf18 through cAMP-mediated pathways.
Retinoic acid regulates gene expression through its receptors, potentially impacting C19orf18 as part of its signaling mechanism. Insulin, through the PI3K/Akt pathway, initiates a series of phosphorylation events that can culminate in the activation of C19orf18, linking it to metabolic control mechanisms. Anisomycin acts as a stress inducer, activating stress-activated protein kinases such as JNK, which may phosphorylate and hence activate C19orf18. Bradykinin, engaging with its G-protein-coupled receptor, can initiate phospholipase C (PLC) activation, increasing intracellular calcium and activating PKC, potentially leading to the phosphorylation of C19orf18 within the inflammatory response. Sphingosine-1-phosphate, through its receptor, may activate downstream kinases that phosphorylate C19orf18 as part of lipid signaling. In a similar vein, Ouabain, Thapsigargin, and A23187 all manipulate intracellular calcium levels, which can activate C19orf18 via calcium-dependent kinases. Hydrogen peroxide, as a reactive oxygen species, may modulate kinase and phosphatase activity, leading to the activation of C19orf18 through redox signaling. Endothelin-1, via its receptor, can trigger signaling involving PKC or MAPKs that may lead to the activation of C19orf18, while Lithium chloride and Sodium orthovanadate operate through the inhibition of enzymes like GSK-3 and phosphatases, respectively, which can result in the phosphorylation and subsequent activation of C19orf18.
SEE ALSO...
Items 11 to 15 of 15 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase (SERCA), causing a rise in cytosolic calcium levels, which can activate calcium-dependent signaling pathways involving kinases that may target and activate C19orf18. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide can act as a signaling molecule, modulating the activity of tyrosine phosphatases and kinases, potentially leading to the oxidative modification and activation of C19orf18 as part of redox signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, potentially activating calcium-dependent kinases that may phosphorylate and activate C19orf18 in cellular signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3), which may lead to the activation of Wnt signaling pathway components, possibly resulting in the activation of C19orf18 within this pathway. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a phosphatase inhibitor that may prevent dephosphorylation of proteins, potentially resulting in the sustained activation of kinases that phosphorylate and activate C19orf18 as part of signal transduction pathways. | ||||||